Oramed Pharmaceuticals, Inc. (ORMP) stock is down -56.53% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives ORMP stock a score of 34 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 27. ORMP's rank also includes a long-term technical score of 44. ORMP has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on ORMP!